Alphabetical list:
A B C D E F G H I J K L M N O P R S T U V W X Y Q Z 1 2 3 4 5 6 7 8 9
News: November 27, 2009
Air Pollution Raises Infants' Risk of Bronchiolitis
November 27, 2009Infants who are exposed to higher levels of air pollution, including vehicle and industrial emissions and wood smoke, are at increased risk for bronchiolitis. The study is unique because it evaluated multiple sources of air pollution and their impact on infants' health.
Bronchiolitis is a common illness of the respiratory tract that is caused by an infection that impacts the minute airways call bronchioles, that lead to the lungs. When these airways become inflamed, they fill with mucus and make breathing difficult. Because infants and young children have especially small airways, they are more susceptible to bronchiolitis. Disease occurrence usually peaks at about 3 to 6 months of age and is more common in children who have not been breastfed.
The new study, which was published in the November 15 issue of the American Journal of Respiratory and Critical Care Medicine, included analysis of nearly 12,000 diagnoses of infant bronchiolitis between 199 and 2002 in southwestern British Columbia. Pollutants monitored included nitric oxide, nitrogen dioxide, carbon monoxide, sulfur dioxide, and particulate matter from monitoring stations within 10 km of where the infants lived.
The researchers found that bronchiolitis was significantly associated to an increased lifetime exposure to specific pollutants. Specifically, with respect to each of the pollutants, the infants' risk increased by 8 percent (nitric oxide), 12 percent nitrogen dioxide) 4 percent (sulfur dioxide), and 13 percent (carbon dioxide). A 6 percent increased risk was found among infants who lived with 50 meters of a highway, and an 8 percent increased risk was associated with wood smoke exposure.
Although the increased risk of bronchiolitis seen in this study was not severe, the authors note that it is important to pay attention to the impact of air pollution because it is so ubiquitous, that bronchiolitis is the main reason children are hospitalized during the first year of life, and that reducing air pollution may be one way to decrease the occurrence of the disease.
Bronchiolitis is often mild, yet some infants are at risk for more severe disease that requires hospitalization. Factors that increase the risk of severe bronchiolitis include prematurity, presence of chronic heart or lung disease, and a weakened immune system associated with illness or medication use. Children who have had bronchiolitis may be more likely to develop asthma later in life as well.
The results of this study may highlight the need for physicians to educate parents about the impact air pollution can have on their infants and how they can avoid it. It also strengthens the relationship between ambient air pollution and the development of respiratory disease among infants and children and why places where children spend a lot of time (e.g., school, playgrounds) should not be near highways and facilities that pollute the air.
SOURCES:
American Thoracic Society
Mayo Clinic
Archive issues: (50)
Archive list: 1 2 3 4 5 6 7 [8] 9 10 11 12 13 14 15 16 17
November 23, 2009 | Genetic Variant Slows AIDS ProgressionScientists report that a genetic variation appears to play a major role in slowing disease progression in HIV-infected patients. In fact, those with the variation appear to take years longer to develop AIDS ...
November 22, 2009 | FDA To Reduce the Misuse of MedicationsThe FDA wants to reduce the misuse of medications, saying that at least 50,000 hospitalizations a year could be prevented if physicians, pharmacists, patients and parents would be more careful. And the cost of these preventable injuries is estimated at about $4 billion annually by the Institute of Medicine. FDA commissioner Margaret A. Hamburg stated, "when I first started looking at this, I was stunned at the scope of the ...
November 21, 2009 | Diabetes Drug Byetta Linked to Kidney ProblemsThe FDA has received 78 reports of kidney problems related to Byetta, a drug by Amylin Pharmaceuticals and Eli-Lilly prescribed to treat type 2 diabetes. With the new findings, the drug's label will be updated to warn doctors and patients about this possible side effect. Byetta (exenatide) was approved in 2005. It's known as an incretin mimetic, which copies the action of incretin GLP-1, a hormone that is released in response to eating food which ...
Related articles:
Treatment - medication (Amitriptyline)
Amitriptyline can reduce symptoms in patients with IC/PBS. Patient overall satisfaction with the therapeutic result of amitriptyline was excellent or good in 46%.Section: Interstitial cystitis
Chronic bacterial prostatitis - signs and symptoms
Chronic bacterial prostatitis is a relatively rare condition - occurs in less than 5% of patients with prostate-related non-BPH lower urinary tract symptoms (LUTS) - that usually presents with an intermittent UTI-type picture and that is defined as recurrent urinary tract infections in men originating from a chronic infection in the prostate. Dr. Weidner, Professor of Medicine, Department of Urology, University of Gie?en, has stated: "In studies of 656 men, we seldom found chronic bacterial prostatitis. It is truly a rare disease. ...Section: Prostatitis
Treatment - medication
As recently as a decade ago, treatments available were limited to the use of astringent instillations, such as chlorpactin (oxychlorosene) or silver nitrate, designed to kill "infection" and/or strip off the bladder lining. In 2005, our understanding of IC/PBS has improved dramatically and these therapies are now no longer done. Rather, IC/PBS therapy is typically multi-modal, including the use of a bladder coating, an antihistamine to help control mast cell activity and a low dose antidepressant to ...Section: Interstitial cystitis